CD3+ CD4+ AND CD3+ CD8+ lymphocyte subgroups and their surface receptors NKG2D and NKG2A in patients with nonsmall cell lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2685-2688

  Yu, Da Ping ^a   Han, Yi ^a   Zhao, Qiu Yue ^a   Liu, Zhi Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Blood; Flow cytometer; Lymphocyte subgroup; Non small cell lung cancer

Indexed keywords

CD3 ANTIGEN; KLRC1 PROTEIN, HUMAN; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ADENOSQUAMOUS CARCINOMA; AGED; CANCER STAGING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOLOGY; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

AGED; ANTIGENS, CD3; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROGNOSIS;

EID: 84899800257     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2685     Document Type: Article

References (18)

1. Deng W, Long L, Li JL, et al. (2014). Mortality of major cancers in Guangxi, China: sex, age and geographical differences from 1971 and 2005. Asian Pac J Cancer Prev, 15, 1567-74.
2. Ganesan AP, Johansson M, Ruffell B, et al. (2013). Tumorinfiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. J Immunol, 191, 2009-17.
3. Huang XE, Tian GY, Cao J, et al. (2013). Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 6663-7.
4. Iyengar P, Gerber DE. (2013). Locally advanced lung cancer: an optimal setting for vaccines and other immunotherapies. Cancer J, 19, 247-62.
5. Kim JL, Cho KH, Park EC, et al. (2014). A single measure of cancer burden combining incidence with mortality rates for worldwide application. Asian Pac J Cancer Prev, 15, 433-9.
6. Kuhn S, Hyde EJ, Yang J, et al. (2013). Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents. J Immunol, 191, 1984-92.
7. Liu G, Lu S, Wang X, et al. (2013). Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis. J Clin Invest, 123, 4410-22.
8. Liu J, Yang XL, Li A, et al. (2014). Epidemiological patterns of cancer incidence in Southern China: based on 6 populationbased cancer registries. Asian Pac J Cancer Prev, 15, 1471-5.
9. Liu J, Hau E, Links M, et al. (2014). Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation. Asia Pac J Clin Oncol, [Epub ahead of print].
10. Mamlouk S, Kalucka J, Singh RP, et al. (2014). Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development. Int J Cancer, 134, 849-58.
11. Park MJ, Bae JH, Chung JS, et al. (2011). Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. Immunol Invest, 40, 367-82.
12. Remark R, Alifano M, Cremer I, et al. (2013). Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin Cancer Res, 19, 4079-91.
13. Sánchez de, Cos Escuín J. (2014). Diagnosis and Treatment of Neuroendocrine Lung Tumors. Arch Bronconeumol, [Epub ahead of print].
14. Wang WJ1, Tao Z, Gu W, et al. (2013). Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 4671-3.
15. Wrobel P, Shojaei H, Schittek B, et al. (2007). Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptorversus NKG2D-dependent recognition. Scand J Immunol, 66, 320-8.
16. Xia YH, Wang ZM, Chen RX, et al. (2013). T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma. Oncol Rep, 30, 1175-84.
17. Xiao ZM, Wang AM, Wang XY, et al. (2013). A study on the inhibitory effect of Solanum lyratum Thunb extract on Lewis lung carcinoma lines. Afr J Tradit Complement Altern Med, 10, 444-8.
18. Zhao Y, Yu D, Wu H, et al. (2014). Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo. Int J Oncol, 44, 451-8.